Why the study?
An aging population with increasing comorbidities requires safer alternatives to standard surgical treatment, prompting evaluation of the clinical and hemodynamic performance, safety, and durability of the sutureless Perceval prosthetic valve.
Population
196 adult patients with aortic valve disease undergoing AVR
Comparison
Aortic valve replacement with Perceval prosthetic valve
Design
Single-center retrospective longitudinal cohort study
Follow-up
Up to a 5-year follow-up
Authors
Loading...
Supports sutureless AVR consideration in select patients; extends observational mid-term data but leaves comparative efficacy open.
The Perceval sutureless bioprosthesis for aortic valve replacement demonstrated high procedural success and excellent safety and hemodynamic performance up to 5 years of follow-up.
Ferreira et al. (2022) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: